Is NBTX or NERV more undervalued in 2026?

CirclFi compares Nanobiotix S.A. (NBTX) and Minerva Neurosciences, Inc (NERV) using 13 institutional-grade valuation models. NBTX has a Quality of Company score of 5.0/10 while NERV scores 3.4/10.

Which is a better buy — NBTX or NERV?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NBTX and NERV valuations compare?

NBTX at $40.40 and NERV at $4.91 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NBTX vs NERV Valuation Comparison 2026 — Intrinsic Value Analysis

NBTX

Pharmaceutical Preparations

Nanobiotix S.A.

Quality

5.0

out of 10

Value Trap

SAFE

Price

$40.40

Last close

Models

6/13

Active

NERV

Pharmaceutical Preparations

Minerva Neurosciences, Inc

Quality

3.4

out of 10

Value Trap

SAFE

Price

$4.91

Last close

Models

6/13

Active

Model-by-Model Comparison

Model	Type	NBTX Fair Value	NBTX Upside	NERV Fair Value	NERV Upside
Bayesian DCF	Intrinsic	$9.42	-76.7%	$1.70	-65.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$41.77	+3.4%	$11.74	+139.1%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NBTX vs NERV — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NBTX vs NERV — Which Stock Is More Undervalued?

NBTX scores higher with a 5.0/10 quality rating vs NERV's 3.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Nanobiotix S.A. (NBTX) and Minerva Neurosciences, Inc (NERV) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NBTX currently trades at $40.40 with a QOC of 5.0/10, while NERV trades at $4.91 with a QOC of 3.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).